Kyttälä Aija, Ihrke Gudrun, Vesa Jouni, Schell Michael J, Luzio J Paul
Cambridge Institute for Medical Research, Department of Clinical Biochemistry, University of Cambridge, Cambridge CB2 2XY, United Kingdom.
Mol Biol Cell. 2004 Mar;15(3):1313-23. doi: 10.1091/mbc.e03-02-0120. Epub 2003 Dec 29.
Batten disease is a neurodegenerative disorder resulting from mutations in CLN3, a polytopic membrane protein, whose predominant intracellular destination in nonneuronal cells is the lysosome. The topology of CLN3 protein, its lysosomal targeting mechanism, and the development of Batten disease are poorly understood. We provide experimental evidence that both the N and C termini and one large loop domain of CLN3 face the cytoplasm. We have identified two lysosomal targeting motifs that mediate the sorting of CLN3 in transfected nonneuronal and neuronal cells: an unconventional motif in the long C-terminal cytosolic tail consisting of a methionine and a glycine separated by nine amino acids [M(X)9G], and a more conventional dileucine motif, located in the large cytosolic loop domain and preceded by an acidic patch. Each motif on its own was sufficient to mediate lysosomal targeting, but optimal efficiency required both. Interestingly, in primary neurons, CLN3 was prominently seen both in lysosomes in the cell body and in endosomes, containing early endosomal antigen-1 along neuronal processes. Because there are few lysosomes in axons and peripheral parts of dendrites, the presence of CLN3 in endosomes of neurons may be functionally important. Endosomal association of the protein was independent of the two lysosomal targeting motifs.
巴顿病是一种神经退行性疾病,由CLN3基因突变引起,CLN3是一种多跨膜蛋白,在非神经元细胞中其主要的细胞内定位是溶酶体。人们对CLN3蛋白的拓扑结构、其溶酶体靶向机制以及巴顿病的发病机制了解甚少。我们提供的实验证据表明,CLN3的N端和C端以及一个大的环结构域都面向细胞质。我们已经鉴定出两个溶酶体靶向基序,它们介导CLN3在转染的非神经元和神经元细胞中的分选:一个位于长的C端胞质尾巴中的非常规基序,由一个甲硫氨酸和一个甘氨酸组成,中间间隔9个氨基酸[M(X)9G],以及一个更传统的双亮氨酸基序,位于大的胞质环结构域中,前面有一个酸性区域。每个基序本身就足以介导溶酶体靶向,但最佳效率需要两者都有。有趣的是,在原代神经元中,CLN3在细胞体的溶酶体和沿神经突含有早期内体抗原-1的内体中都很明显。由于轴突和树突外周部分的溶酶体很少,CLN3在神经元内体中的存在可能在功能上很重要。该蛋白与内体的结合独立于两个溶酶体靶向基序。